Invitation to iCMLf Forum for physicians attending ASH 2017

Invitation to iCMLf Forum for physicians attending ASH 2017

Each year The Max Foundation and the International CML Foundation come together during the American Society of Hematology (ASH) Meeting to host a forum for physicians treating chronic myeloid leukemia (CML) in low resource settings. The aim is to provide resources, share programmatic updates and enable robust discussions between leading CML experts and those treating the disease in low- and middle-income countries. This year’s forum will have a new component of small group discussions to allow for a more intimate question & answer session.

If you are a physician attending ASH this year, please join us at the iCMLf Forum for Physicians from Emerging Economic Regions, carried out in partnership with The Max Foundation, on Friday 8th December at 12.30pm. The iCMLf Forum is a unique experience to discuss and share experiences from all around the world. We hope to hear yours!

The 2017 Forum features ‘Perspectives on the Management of CML’ covering the topics of Molecular Monitoring for CML and Treatment Free Remission. Speakers include Dr. Susan Branford (Australia), Dr. Katia Pagnano (Brazil) and Dr. Susanne Saussele (Germany). This year, there is an expanded format for physicians from low- and middle-income countries to “Meet the Expert” at the end of the meeting.  In the small group sessions, physicians will be able to hear from and chat with CML experts around the management of TKIs.

The iCMLf Forum for Physicians from Emerging Regions will be held:

12.30pm – 3:30 pm on Friday 8th December
at the Doubletree Downtown Atlanta, Georgia, USA

If you are traveling to ASH this year, please consider joining this meeting. Feel free to share this email and the attached invitation with your colleagues.  Please click here to reserve your place or for any queries please email melissa@cml-foundation.org.

Thanks, as always, for your support!

The Max Foundation is a leading global health nonprofit organization dedicated to accelerating health equity. For 28 years, Max has pioneered practical, scalable, high-quality solutions to bring life-extending treatments and patient-centered health care to more than 100,000 people living with cancer and critical illness in low- and middle-income countries. Max believes in a world where all people can access high-impact medicines, where geography is not destiny, and where everyone can strive for health with dignity and with hope.

Related Articles

  • Pat Garcia-Gonzalez Wins UICC’s CEO Award

    Pat Garcia-Gonzalez Wins UICC’s CEO Award

    The Max Foundation is thrilled to announce that Pat Garcia-Gonzalez has won the UICC’s CEO Award for 2018!

  • The Max Foundation (Max) and its Partners Unveil Breakthrough Cancer Care Commitment to Double Their Impact and Reach 100,000 Patients Annually by 2030

    The Max Foundation (Max) and its Partners Unveil Breakthrough Cancer Care Commitment to Double Their Impact and Reach 100,000 Patients Annually by 2030

    Building on two decades of progress, Max’s ambitious goal will expand its proven, patient-centered model that has already helped more than 100,000 people access treatment Commitment will enhance local health system capabilities to deliver innovative and generic medicines, diagnostics, and treatment in more than 80 low- and middle-income countries Alongside this commitment, Max and Novartis sign….

  • Am I Doing Enough?

    Am I Doing Enough?

    By Pat Garcia-Gonzalez Birthdays are a time to take stock on our life. This birthday, I feel unsettled, questioning if I am doing everything I can. A few weeks ago, I sat in a small consult room. A gentleman walked wearing gray slacks, a white buttoned shirt, and suit coat, he must have been in….